Wake Forest researcher reports cholesterol-lowering drug reduces strokes

November 08, 1999

WINSTON-SALEM, N.C. - A drug already being used to lower cholesterol and prevent heart attacks sharply reduced strokes in patients who already had heart disease, a Wake Forest University researcher told the American Heart Association meeting today (Nov. 8) in Atlanta.

Robert P. Byington, Ph.D., professor and head of the Section on Epidemiology, said the drug, pravastatin, reduced stroke by 20 percent, compared to placebo, in patients with heart disease or high cholesterol.

The study "offers a major new way to lower the stroke rate," Byington said.

He said the drug reduced the risk of stroke over a wide range of cholesterol values and among a wide spectrum of patients in pooled data from three similar clinical trials. The effect occurred primarily in the patients who already had coronary heart disease, where the reduction was 22 percent.

The Prospective Pravastatin Pooling Project began in 1992, before any of the three clinical trials were completed. The three trials - WOS (West of Scotland coronary prevention study), CARE (Cholesterol And Recurrent Events) and LIPID (Long-term Intervention with Pravastatin in Ischemic Disease) totaled 19,768 participants from Scotland, the United States, Canada and Australia-New Zealand.

All were randomized clinical trials that compared 40 milligrams per day of pravastatin to an inert placebo. WOS was conducted in patients with very high cholesterol levels, while CARE and LIPID involved coronary heart disease patients. The data was collected as the studies were underway, with patients remaining in the study an average of five years.

Over the course of the three studies, a total of 267 patients on pravastatin had strokes, compared to 331 patients on the placebo, a statistically significant difference. The stroke rate declined from 6.5 per thousand per year in the placebo group to 5.2 per thousand in the pravastatin group. Most of the strokes were non-fatal; the number of fatal strokes was just about the same in both groups.

The drug prevented the type of stroke caused by the blocking of an artery in the brain, a situation similar to the blocking of a coronary artery in the heart (which leads directly to a heart attack.)

He noted that the effect on stroke was somewhat unexpected. "People have been combining the results from lipid [cholesterol] lowering trials for years and even as late as 1992, in one of the last analyses, there was zero difference in strokes between the groups that were on lipid-lowering drugs and the people who were on placebo."

These earlier studies were done with other kinds of drugs that lower cholesterol. When the class of drugs called statins became available in the late 1980s, "we began seeing a much larger reduction in lipid levels, and amazingly, hints of reduction in stroke - and we weren't expecting to see that at all."

The new study is strong evidence that pravastatin reduces strokes.

About 600,000 people suffer a non-fatal strokes each year in the United States, and these strokes are a leading cause of serious long-term disability and extensive and expensive rehabilitation.

The Prospective Pravastatin Pooling Project was funded by Bristol Myers Squibb, as were WOS, CARE and LIPID.
-end-


Wake Forest Baptist Medical Center

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.